195 Results

People

  1. Mulhall
    Mulhall
  2. Eastham
    Eastham
  3. Lilja
    Lilja
  4. Bochner
    Bochner
  5. Scardino
    Scardino
  6. Nelson
    Nelson
  7. Vickers
    Vickers
  8. Herr
    Herr
  9. Russo
    Russo
  10. Sandhu
    Sandhu

Groups

  1. Surgery (195)
  2. Urology (195)
  3. Population Sciences Research Program (68)
  4. Epidemiology and Biostatistics (50)
  5. Sloan Kettering Institute Faculty (39)
  6. Molecular Pharmacology and Chemistry Program Faculty (37)
  7. Health Outcomes Research Group (34)
  8. Department of Medicine (33)
  9. Survivorship Research (32)
  10. Genitourinary Oncology Service (30)
  1. "Urology"
  2. "2012"
Formats
  1. Journal Article (131)
  2. Meeting Abstract (59)
  3. Book Section (3)
  4. Conference Paper (2)
Groups
  1. Surgery (195)
  2. Urology (195)
  3. Population Sciences Research Program (68)
  4. Epidemiology and Biostatistics (50)
  5. Sloan Kettering Institute Faculty (39)
  6. Molecular Pharmacology and Chemistry Program Faculty (37)

More Groups

People
  1. John Mulhall (45)
  2. James Eastham (37)
  3. Peter Scardino (32)
  4. Hans Lilja (24)
  5. Bernard Bochner (21)
  6. Andrew Vickers (16)

More People

Years
  1. 2012 (195)
Publications
  1. Journal of Sexual Medicine (29)
  2. BJU International (27)
  3. European Urology (19)
  4. Journal of Clinical Oncology (17)
  5. Urology (14)
  6. Journal of Urology (10)

More Publications

Publishers
  1. Elsevier Inc. (45)
  2. Elsevier Science, Inc. (44)
  3. Wiley Blackwell (33)
  4. American Society of Clinical Oncology (17)
  5. Springer (7)
  6. Nature Publishing Group (6)

More Publishers

Results (195)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Muscle-invasive urothelial carcinoma: Conventional and variant subtypes
    Book Section

    Taylor, J. M.; Bochner, B.; Amin, M. B.; Hansel, D. E.
    In Hansel, D. E.; McKenney J. K.; Stephenson, A. J.; Chang, S. S. (Eds.) The Urinary Tract: A Comprehensive Guide to Patient Diagnosis and Management (2012)

    Fulltext@MSK | Save
  • The analytic validation of prostate-specific mRNA detection in whole blood by RT-PCR as a prognostic biomarker for patients with castration- resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Next-generation point-of-care immunoassay system for rapid and accurate determination of cancer markers in the physician office
    Meeting Abstract

    Zappala, S. M.; Libertino, J. A.; Wein, A. J.; Vaughan, E. D.; Scardino, P. T.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Genetic determinants of long-term response to rapalog therapy in advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Scott, S. N.; Takeda, S.; Liu, H.; Chen, Y.; Motzer, R. J.; Berger, M. F.; Hsieh, J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Incidence-based analysis of lethal prostate cancer in Swedish counties with high versus low incidence of prostate cancer in nationwide, population-based registries
    Meeting Abstract

    Stattin, P.; Holmstrom, B.; Robinson, D.; Vickers, A. J.; Lilja, H.; Hugosson, J.; Jonsson, H.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Post-prostatectomy PSA slope (ProsVue) in Gleason score >= 7 disease
    Meeting Abstract

    Moul, J. W.; Lilja, H.; Semmes, O. J.; Vessella, R.; McDermed, J. E.; Sarno, M. J.; Klem, R. E.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Defining the genetic basis of everolimus sensitivity in metastatic bladder cancer (MBC) by whole-genome sequencing (WGS)
    Meeting Abstract

    Iyer, G.; Milowsky, M. I.; Al-Ahmadie, H.; Hanrahan, A.; Janakiraman, M.; Heguy, A.; Viale, A.; Socci, N. D.; Sander, C.; Bochner, B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Development of a nomogram model using a very large sample of patients (pts) to predict the risk of (99m)Tc-bone scan (BS) positivity in pts receiving androgen deprivation therapy (ADT) for prostate cancer (PCa)
    Meeting Abstract

    Gotto, G.; Yu, C.; Bernstein, M.; Eastham, J. A.; Kattan, M. W.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Serum tumor marker (STM) decline rates during high-dose chemotherapy (HDCT) to predict outcome for germ cell tumor (GCT) patients (pts)
    Meeting Abstract

    Feldman, D. R.; Voss, M. H.; Jia, X.; Van Alstine, L. J.; Patil, S.; Fischer, P.; Sheinfeld, J.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Balar, A. V.; Iyer, G.; Apolo, A. B.; Regazzi, A. M.; Garcia-Grossman, I. R.; Pendse, D.; Ostrovnaya, I.; Chou, J. F.; Bochner, B.; Dalbagni, G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save